- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Mallinckrodt reports restructuring
The slowdown in the medicalimaging market appears to have caught up with pharmaceutical firmMallinckrodt Medical. The company's parent, Mallinckrodt Group,is restructuring the division to respond to changes driven byhealth-care reform. Mallinckrodt
The slowdown in the medicalimaging market appears to have caught up with pharmaceutical firmMallinckrodt Medical. The company's parent, Mallinckrodt Group,is restructuring the division to respond to changes driven byhealth-care reform.
Mallinckrodt Group's medical unit has traditionally been oneof the strongest performers in the company's three divisions,which include chemical and veterinary businesses. The companyexpects Mallinckrodt Medical's sales and earnings this year togrow 15% over last year, despite increased price discounting anda moderation in the pace of sales growth.
St. Louis-based Mallinckrodt Medical has decided to slim downto adapt to the increasingly competitive health-care environment,however. The company will shed about 10% of its 5000 employeesworldwide. Mallinckrodt Medical will begin implementing the programearly in fiscal year 1995 (end-June), with the program completedby 1996.
The restructuring is expected to save Mallinckrodt Medical$40 million a year. Short-term, however, Mallinckrodt Medicalwill take a one-time pretax restructuring charge of $80 millionin the fourth quarter.
A first step in the restructuring will be a revamping of MallinckrodtMedical's U.S. sales structure. The company's five divisionalsales groups will be replaced with a unified sales organizationheaded by a senior executive.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
